Skip to content
RelibillMedical Billing

Specialty

Endocrine billing is complexity, devices, and drugs that need a policy.

Endocrinology claims are heavy on E/M for diabetes, thyroid disease, and osteoporosis, plus interpretation of continuous glucose data when the practice actually performs that service, and infusions that need authorization. Supplies dispensed from the office are not the same as a professional visit.

Specialty rules are applied to the practice's payers, documentation, and schedule during the engagement.

Where the billing gets difficult

Device data billed without an interpretation

A download from a pump or sensor is not a code by itself. The interpretation and the interaction have to be documented.

Infusion authorizations

Osteoporosis and other infusion drugs are denied when the auth, the dose, or the interval does not match the policy.

High E/M supported only by a medication list

A long list of insulin doses is not medical decision making unless the note shows what was changed and why.

Coding considerations

E/M based on decisions

Medication changes, lab review, and risk are coded from the assessment. Stable refills are not automatically high level.

Device services

Interpretation codes are used only when the practice's note meets the code and a separate entity is not already billing it.

Drug administration

Infusion time and drug units follow the administration record. The drug code and the admin code are both required when both were provided.

Documentation the claim needs

  • What changed in the regimen and why
  • Interpretation of device data when that service is billed
  • Infusion start and stop times
  • Authorization number and interval for scheduled drugs

Reimbursement complexity

Endocrinology cash is mostly E/M plus a smaller set of high-dollar drug administrations. The drug claim can dwarf the visit and can be lost to a single authorization error. Continuous glucose and pump work is a documentation trap: patients assume the download is included, and payers expect a defined service. Labs drawn in the office need a decision about whether the practice bills the lab or sends it out. Double billing a reference lab is a compliance problem, not a win.

Proposed approach

  1. 01

    Separate drug visits from cognitive visits

    Infusion days have an auth checklist. Clinic days have an E/M checklist. They are not the same queue.

  2. 02

    Bill device services from the interpretation

    Downloads without a signed interpretation are held.

  3. 03

    Clarify lab ownership

    In-office labs and send-out labs are listed so only the performed component is billed.

Workflow checks

  • Regimen-change coding review
  • Infusion auth and time capture
  • Device interpretation queue
  • Lab ownership check

Questions

Do you bill diabetic supplies as DME?

Only if the practice is enrolled to supply them and the engagement includes that work. Most endocrine engagements are professional services, not a supply company.

Can CGM interpretation be added to every diabetes visit?

No. The code has its own requirements. Adding it because a patient wears a sensor is not supported coding.

Related services

Talk through endocrinology billing.

Bring the queues you can already name. Leave patient identifiers off the form.

Contact the office